As a long-term consequence of ligature-induced periodontitis, not only tissue gingival inflammation measured by extravasation increased but there was also a considerable bone loss in the periodontium
Focus less on the side and more on the pattern: sudden onset, additional red flags (chest pressure, jaw pain, shortness of breath, facial droop, slurred speech), and whether symptoms persist or worsen
Advanced AMD is categorized into dry and neovascular (nvAMD) forms (217)
Using artificial intelligence, they, in essence, listened into the patient grapevine of 400,000 Reddit posters
You may qualify for a semaglutide or tirzepatide lawsuit if: You took Ozempic , Wegovy , Rybelsus , Mounjaro , or similar GLP-1 medication You developed a serious side effect such as gastroparesis , ileus , persistent vomiting , NAION (vision loss) , or gallbladder disease You sought medical treatment or hospitalization You have documentation of your prescriptions and diagnosis You do not have disqualifying preexisting conditions (e.g., prior gastric surgery) Your claim is within the applicable statute of limitations To support your claim, we may request: Pharmacy or prescription records Medical records confirming diagnosis and treatment Emergency room, specialist, or hospital records Timeline of symptom onset and drug use Records of financial or emotional hardship (e.g., lost income, pain and suffering) Successful lawsuits may result in compensation for: Past and future medical expenses Lost income and reduced earning ability Pain, suffering, and loss of enjoyment of life Emotional distress Ongoing care needs or feeding support Wrongful death damages , if a loved one passed away Lawsuits filed against Eli Lilly (maker of Mounjaro) and Novo Nordisk (maker of Ozempic and Wegovy) allege: Failure to provide adequate warnings on labels Marketing the drugs off-label for weight loss without safety studies Delaying updates despite mounting reports of gastroparesis and hospitalization Misrepresenting the long-term risks These manufacturers have a legal duty to inform users about serious side effects
Elderly women exhibit a reduced number of circulating pDCs compared to younger women
